U.S. Markets are not yet open, but PRGO is being traded in the pre-market session. Pre-Market quote »
|96.67|| +0.22 / +0.23%|
Perrigo Co. Plc engages in the production of over-the-counter consumer goods and specialty pharmaceutical products. It operates through the following segments: Consumer Healthcare (CHC), Branded Consumer Healthcare (BCH), Prescription Pharmaceuticals, and Specialty Sciences. The CHC segment includes the company's former segments, which are the Nutritionals and Israel Pharmaceuticals and Diagnostics business. The BCH segment consists of the Omega business. The Prescription Pharmaceuticals includes the Rx Pharmaceuticals business. The Specialty Sciences segment comprises of the assets, which focuses on the treatment of multiple sclerosis. The company was founded in 1887 and is headquartered in Dublin, Ireland.
|John T. Hendrickson||President & Chief Executive Officer|
|Judy L. Brown||Chief Financial Officer & Executive Vice President|
|Thomas Farrington||Chief Information Officer & Executive VP|
|Todd W. Kingma||Secretary, Executive VP & General Counsel|
|Sharon Kochan||Executive Vice President & GM-International|